OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma
Lavinia Patricia Mocan, Rareș Crăciun, Cristiana Grapă, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 4, pp. 1003-1014
Open Access | Times Cited: 11
Lavinia Patricia Mocan, Rareș Crăciun, Cristiana Grapă, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 4, pp. 1003-1014
Open Access | Times Cited: 11
Showing 11 citing articles:
Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
Giorgio Frega, Fernando P. Cossío, Jesús M. Bañales, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2098-2098
Open Access | Times Cited: 21
Giorgio Frega, Fernando P. Cossío, Jesús M. Bañales, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2098-2098
Open Access | Times Cited: 21
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5
The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value
Lavinia Patricia Mocan, Ioana Rusu, Carmen Stanca Melincovici, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 13
Lavinia Patricia Mocan, Ioana Rusu, Carmen Stanca Melincovici, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 13
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies
Antonella Cammarota, Rita Balsano, Tiziana Pressiani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 272-272
Open Access
Antonella Cammarota, Rita Balsano, Tiziana Pressiani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 272-272
Open Access
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Thaleia-Eleftheria Bousou, Panagiotis Sarantis, Ioanna A. Anastasiou, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 555-555
Open Access
Positivity Rate of PD-L1 Expression and Its Clinical Significance in Vulvar Cancer: A Systematic Review and Meta-Analysis
Stefanos Flindris, Chrysoula Margioula‐Siarkou, Christos V. Chalitsios, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4594-4594
Open Access
Stefanos Flindris, Chrysoula Margioula‐Siarkou, Christos V. Chalitsios, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4594-4594
Open Access
Programmed death-ligand 1 expression in carcinoma of unknown primary
Hye Min Kim, Ja Seung Koo
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Hye Min Kim, Ja Seung Koo
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer
Shuyuan Zhang, Jianhua Nie, Sheng Tai, et al.
BMJ Case Reports (2023) Vol. 16, Iss. 12, pp. e255403-e255403
Closed Access | Times Cited: 5
Shuyuan Zhang, Jianhua Nie, Sheng Tai, et al.
BMJ Case Reports (2023) Vol. 16, Iss. 12, pp. e255403-e255403
Closed Access | Times Cited: 5
Sex Matters–Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer
Benjamin Schulz, Emily Leitner, Tim Schreiber, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1901-1901
Open Access | Times Cited: 1
Benjamin Schulz, Emily Leitner, Tim Schreiber, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1901-1901
Open Access | Times Cited: 1
Prognostic nomogram for cholangiocarcinoma after immunotherapy
Chao Chen, Zhan Shi, Xiaoyuan Chu, et al.
Research Square (Research Square) (2024)
Open Access
Chao Chen, Zhan Shi, Xiaoyuan Chu, et al.
Research Square (Research Square) (2024)
Open Access
Correlation of PDL-1 Expression with Tumour Budding and Tumour Infiltrating Lymphocytes in Colorectal Cancers
Tejasvita Singh, Anshul Singh, Manoj Kumar Bind, et al.
Asian Pacific Journal of Cancer Biology (2023) Vol. 8, Iss. 2, pp. 147-153
Open Access
Tejasvita Singh, Anshul Singh, Manoj Kumar Bind, et al.
Asian Pacific Journal of Cancer Biology (2023) Vol. 8, Iss. 2, pp. 147-153
Open Access
